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Abstract Background: -tiation. They are used extensively to treat several diseases. Traditionally, mesenchymal stem cells are cultured in serum-containing media, typically supplemented with fetal bovine serum (FBS). However, the variability of FBS is likely to skew experimental results. Although serumfree media used to expand mesenchymal stem cells has facilitated remarkable achievements, immunomodulation of these cells in under serum-free conditions is poorly understood.
erful immunoregulatory functions in vitro and in vivo. Design and Methods: Immunosuppressive activity and the immunomodulatory cytokines produced by mesenchymal stem cells in serum-free media were characterized in vitro. Immunomodulation by serum-free mesenchymal stem cell expansion in monocrotaline-induced pulmonary hypertension was explored in vivo. Results: Similar to cells in serum-containing media, mesenchymal stem cells expanded in serum-free media inhibited proliferation and apoptosis of CD4 + T cells. They also exhibited strong immunosuppressive activities and secreted high levels of immunomodulatory cytomesenchymal stem cells in serum-free media attenuated pulmonary vascular remodeling and
Conclusions:
modulatory function in vitro and in vivo; serum-free media may replace serum-containing media for basic research and clinical applications.
Introduction
Mesenchymal stem cells (MSCs) are a rare population of multipotent progenitor cells. 6 In vitro to traditional culture medium in primary cell isolation, multipassage expansion, mesoderm in vitro immunomodulation. 
Materials and Methods

Isolation and expansion of UC-MSCs
UC-MSCs expansion in SFM UC-MSCs differentiation and staining assays
